Projects

MUDr. Miroslav Vlček, PhD.
Scientific Director

International

Current
  • Alliance4Life Bridging the Research and Innovation Gap in Life Sciences
    Program: Horizon Europe
    Duration: 1. 3. 2024 – 29. 2. 2028

National

Finished
  • Modulation of individual types of IP3 receptors in carcinogenesis and their impact on the effect of chemotherapeutics
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • Effect of physical activity and nutrition on gut microbiota modification in healthy subjects and patients with a non - communicable diseases
    Program: SRDA
    Duration: 1. 8. 2018 – 30. 6. 2022
  • Physiological relevance of medical and pharmaceutical sciences.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2020
  • Multiple sclerosis - The role of mitochondrial dysfunction in insulin resistance.
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Study of biological effects of H2S/NO products and molecular mechanism of their actions
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 10. 2020
  • Functional Consequences of C1858T Polymorphism in PTPN22 Gene on T cell differentiation: A Bioinformatic Approach.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 1. 2014
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • Development of the Centre for Molecular Medicine of the Slovak Academy of Sciences as a unique modern clinical research unit in Slovakia
    Program:
    Duration: 1. 8. 2009 – 31. 3. 2011
Employees